Business Context and Reporting Period
Company: On Assignment, Inc. (Note: Input metadata listed "Everforth Inc," but the filing text identifies the registrant as On Assignment, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2003
Business Overview: A leading provider of skilled temporary professionals to clients in the science and healthcare industries. Operations are divided into two segments: Healthcare Staffing and Lab Support.
Key Financial Metrics
| Metric | Q1 2003 | Q1 2002 |
|---|---|---|
| Revenues | $57,825,000 | $42,111,000 |
| Gross Profit | $15,480,000 | $13,545,000 |
| Gross Margin | 26.8% | 32.2% |
| Operating Income (Loss) | $(863,000) | $4,210,000 |
| Net Income (Loss) | $(452,000) | $2,869,000 |
| EPS (Basic) | $(0.02) | $0.13 |
| Cash and Equivalents | $29,488,000 | $95,256,000 (End of Q1 2002) |
| Working Capital | $52,822,000 | N/A |
| Total Debt | None reported | None reported |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 37.3% to $57.8 million, driven primarily by the April 2002 acquisition of Health Personnel Options Corporation (HPO), which contributed $25.9 million in revenue. Excluding HPO, organic revenue decreased 24.3% due to weaker demand in the biotechnology sector and general economic conditions.
- Profitability Decline: The company reported a net loss of $452,000 compared to a net income of $2.9 million in the prior year. Operating income turned negative ($863,000 loss) from a $4.2 million profit.
- Margin Compression: Gross margin declined from 32.2% to 26.8%. The Healthcare Staffing segment's cost of services as a percentage of revenue increased to 77.3% (from 67.8%), largely due to the higher cost structure of the HPO acquisition.
- Segment Performance:
- Lab Support: Revenues decreased 16.9% to $24.5 million due to a 20.4% drop in temporary professionals on assignment and a 35.7% drop in conversion fees.
- Healthcare Staffing: Revenues increased 64.3% to $33.3 million, but the segment reported an operating loss of $3.3 million compared to $1.2 million profit in 2002.
- Cash Flow: Operating cash flow was negative $2.0 million, primarily due to working capital funding. Investing activities provided $3.0 million, including a $2.5 million recovery of HPO escrow funds.
Guidance, Outlook, and Risks
- Restructuring Costs: The company incurred $413,000 in severance and office closure costs in March 2003 related to a lower-cost division within the Healthcare Staffing segment. These costs are included in SG&A expenses.
- Seasonality: Management notes that demand typically declines from year-end through February, resulting in lower first-quarter results. The Lab Support segment also faces seasonal declines in Q2 and Q3.
- Competition: Increased price competition in the nurse travel business from local start-ups is noted as a risk to margins and market share.
- Capital Expenditures: The company is implementing a PeopleSoft enterprise-wide IT system. Approximately $4.3 million has been capitalized, with an additional $2 million to $3 million expected over the next nine months.
- Stock Repurchases: The company repurchased 920,300 shares for $3.7 million during the quarter. 496,700 shares remain authorized for repurchase.
- Goodwill Impairment Risk: While no impairment was recorded as of December 31, 2002, management noted that a permanent decline in market value could trigger a review of goodwill ($123.8 million) and indefinite-lived intangible assets.
Investor Verification Checklist
- Organic Growth: Verify the sustainability of revenue growth excluding the HPO acquisition, given the 24.3% organic decline.
- Margin Recovery: Assess the timeline for margin improvement in the Healthcare Staffing segment following the integration of HPO and recent cost-cutting measures.
- Working Capital: Monitor the trend in accounts receivable, which increased by $4.7 million, and the associated cash burn in operating activities.
- IT Implementation: Track the completion and cost overruns of the PeopleSoft system implementation.
- Goodwill Valuation: Review future quarterly reports for any triggers related to goodwill impairment testing given the company's market value fluctuations.